Diwata Macalino

CK2 Inhibitor CX-4945 Suppresses DNA Repair Response Triggered by DNA-Targeted Anticancer Drugs and Augments Efficacy: Mechanistic Rationale for Drug Combination Therapy

Adam Siddiqui-Jain, Joshua Bliesath, Diwata Macalino et al. · Molecular Cancer Therapeutics · 2012 · 98 citations

Dna-targeted Anticancer Drugs, Cancer Biology, Dna Repair Response +19

Discovery of CX-6258. A Potent, Selective, and Orally Efficacious pan-Pim Kinases Inhibitor

Mustapha Haddach, Jerome Michaux, Michael K. Schwaebe et al. · ACS Medicinal Chemistry Letters · 2011 · 84 citations · Full text

Pim Kinases, Pharmacotherapy, A Potent +18

7-(4H-1,2,4-Triazol-3-yl)benzo[c][2,6]naphthyridines: A novel class of Pim kinase inhibitors with potent cell antiproliferative activity

Fabrice Pierre, Eric Stefan, Anne-Sophie Nédellec et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 52 citations · Full text

Medicinal Chemistry, Biochemistry, Medicine +11

Novel potent dual inhibitors of CK2 and Pim kinases with antiproliferative activity against cancer cells

Fabrice Pierre, Collin F. Regan, Marie-Claire Chevrel et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 35 citations · Full text

Antiproliferative Activity, Medicine, Receptor Tyrosine Kinase +7

Synthesis and SAR of inhibitors of protein kinase CK2: Novel tricyclic quinoline analogs

Mustapha Haddach, Fabrice Pierre, Collin F. Regan et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 16 citations · Full text

Medicinal Chemistry, Biochemistry, Protein Kinase Ck2 +7